Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1928
  • Home
  • Print this page
  • Email this page
BRIEF COMMUNICATION
Year : 2016  |  Volume : 64  |  Issue : 9  |  Page : 681-682

Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis


1 Department of Uvea, Aditya Birla Sankara Nethralaya, Kolkata, West Bengal, India
2 Department of Uvea, Vision Research Foundation, Sankara Nethralayai, Chennai, Tamil Nadu, India

Correspondence Address:
Dr. Avirupa Ghose
Aditya Birla Sankara Nethralaya, 147, Mukundapur, E.M. Bypass, Kolkata - 700 099, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.194335

Rights and Permissions

Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed526    
    Printed4    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal